Primary Central Nervous System Lymphoma in the Transplant Patient

Bailey, 1929, Intracranial sarcomatous tumours of leptomeningeal origin, Arch Surg, 18, 1359, 10.1001/archsurg.1929.01140130449031 Berry, 1981, Radiation therapy in the management of primary malignant lymphoma of the brain, Int J Radiat Oncol Biol Phys, 7, 55, 10.1016/0360-3016(81)90060-2 Birkeland, 1975, Renal transplantation and cancer: The scandia transplant material, Tissue Antigens, 6, 28, 10.1111/j.1399-0039.1975.tb00608.x Birkeland, 1983, Cancer in transplanted patients: The scandia-transplant material, Transplant Proc, 15, 1071 Bonnin, 1987, Primary malignant non-Hodgkin’s lymphoma of the central nervous system, Pathol Ann, 22, 353 Burnet, 1965, Somatic mutation and chronic disease, Br Med J, 1, 338, 10.1136/bmj.1.5431.338 Briggs, 1978, Infectious mononucleosis, herpes simplex infection, and diffuse lymphoma in a renal transplant recipient, Transplantation, 25, 227, 10.1097/00007890-197804000-00016 Cheeseman, 1980, Epstein-Barr virus infections in renal transplant recipients, Ann Intern Med, 93, 39, 10.7326/0003-4819-93-1-39 Chang, 1973, Prevalence of orpharyngeal excreters of leukocytetransforming agents among a human population, N Engl J Med, 289, 1325, 10.1056/NEJM197312202892501 Chang, 1978, Oropharyngeal excretion of Epstein-Barr virus by patients with lymphoproliferative disorders and by recipients of renal homografts, Ann Intern Med, 88, 34, 10.7326/0003-4819-88-1-34 Cleary, 1984, Monoclonality of lymphoproliferative lesions in cardiac-transplant recipients, N Engl J Med, 310, 477, 10.1056/NEJM198402233100801 Crawford, 1981, Studies on long-term cell mediated immunity to Epstein-Barr virus in immunosuppressed renal allograft recipients, Int J Cancer, 28, 705, 10.1002/ijc.2910280608 Deeg, 1984, Bone marrow transplantation: A review of delayed complications, Br J Haematol, 57, 185, 10.1111/j.1365-2141.1984.tb02887.x Ehrlich, 1957, Uber den jetzigen Stand der Karzinomforschung, Vol 2, 550 Hanto, 1981, Clinical spectrum of lymphoproliferative disorders in renal transplant recipients and evidence for the role of Epstein-Barr virus, Cancer Res, 41, 4253 Hanto, 1982, Epstein-Barr virus-induced B-cell lymphoma after renal transplantation, N Engl J Med, 306, 913, 10.1056/NEJM198204153061506 Hanto, 1985, Epstein-Barr virus, immunodeficiency, and B cell lymphoproliferation, Transplantation, 39, 461, 10.1097/00007890-198505000-00001 Helle, 1984, Primary lymphoma of the central nervous system: Clinicopathological study of experience at Stanford, J Neurosurg, 60, 94, 10.3171/jns.1984.60.1.0094 Henle, 1979, The Epstein-Barr virus, Sei Am, 241, 48 Henle, 1979, The virus as the etiologic agent of infectious mononucleosis, 297 Henry, 1974, Primary malignant lymphoma of the CNS, Cancer, 34, 1293, 10.1002/1097-0142(197410)34:4<1293::AID-CNCR2820340441>3.0.CO;2-P Herberman, 1982 Hertel, 1977, Lymphoproliferative disorders in organ transplant recipients, Lab Invest, 36, 340 Hochberg, 1983, Central nervous system lymphoma related to Epstein-Barr virus, N Engl J Med, 309, 745, 10.1056/NEJM198309293091301 Hoover, 1973, Risk of cancer in renal-transplant recipients, Lancet, 2, 55, 10.1016/S0140-6736(73)93256-X Kinlen, 1979, Collaborative United Kingdom-Australasian study of cancer in patients treated with immunosuppressive drugs, Br Med J, 2, 1461, 10.1136/bmj.2.6203.1461 Kinlen, 1982, Immunosuppressive therapy and cancer, Cancer Surv, 4, 565 Krikorian, 1978, Malignant neoplasms following cardiac transplantation, JAMA, 240, 639, 10.1001/jama.1978.03290070041012 Levitt, 1980, CNS involvement in the non-Hodgkin’s lymphomas, Cancer, 45, 545, 10.1002/1097-0142(19800201)45:3<545::AID-CNCR2820450322>3.0.CO;2-6 Lipinski, 1980, Dissociation of natural killer cell activity and antibody-dependent cell-mediated cytotoxicity in kidney allograft recipients receiving high-dose immunosuppressive therapy, Transplantation, 29, 214, 10.1097/00007890-198003000-00010 Littman, 1975, Reticulum cell sarcoma of the brain: A review of the literature and study of 19 cases, Cancer, 35, 1412, 10.1002/1097-0142(197505)35:5<1412::AID-CNCR2820350526>3.0.CO;2-T Loeffler, 1985, Primary lymphomas of the central nervous system: Patterns of failure and factors that influence survival, J Clin Oncol, 3, 490, 10.1200/JCO.1985.3.4.490 MacKintosh, 1982, CNS involvement in non-Hodgkin’s lymphoma: An analysis of 105 cases, Cancer, 49, 586, 10.1002/1097-0142(19820201)49:3<586::AID-CNCR2820490331>3.0.CO;2-C Matas, 1976, Post-transplant malignant lymphoma, Am J Med, 61, 716, 10.1016/0002-9343(76)90151-0 Mendenhall, 1983, Primary lymphoma of the central nervous system, Cancer, 52, 1993, 10.1002/1097-0142(19831201)52:11<1993::AID-CNCR2820521104>3.0.CO;2-C Murray, 1986, Primary malignant lymphoma of the central nervous system, J Neurosurg, 65, 600, 10.3171/jns.1986.65.5.0600 Patchell, 1985, Neurologic complications of bone marrow transplantation, Neurology, 35, 300, 10.1212/WNL.35.3.300 Penn, 1969, Malignant lymphomas in transplantation patients, Transplant Proc, 1, 106 Penn, 1972, Malignant tumors arising de novo in immunosuppressed organ transplant recipients, Transplantation, 14, 407, 10.1097/00007890-197210000-00001 Penn, 1982, Malignancies following the use of cyclosporin A in man, Cancer Surv, 1, 621 Penn, 1978, Tumors arising in organ transplant recipients, Adv Cancer Treat, 28, 31 Posner, 1987, Primary lymphoma of the CNS, Neurol Alert, 5, 21 Purtilo, 1980, Epstein-Barr virus-induced oncogenesis in immune-deficient individuals, Lancet, 1, 300, 10.1016/S0140-6736(80)90792-8 Purtilo, 1983, Oncological consequences of impaired immune surveillance against ubiquitous viruses, J Clin Immunol, 3, 197, 10.1007/BF00915343 Rampen, 1980, Radiation therapy in primary non-Hodgkin’s lymphomas of the CNS, Eur J Cancer, 16, 177, 10.1016/0014-2964(80)90149-8 Royston, 1975, Cell-mediated immunity to Epstein-Barr virus-transformed lymphoblastoid cells in acute infectious mononucleosis, N Engl J Med, 293, 1159, 10.1056/NEJM197512042932301 Sanders, 1982, Glioblastoma multiforme in a patient with acute lymphoblastic leukemia who received a bone marrow transplant, Transplant Proc, 14, 770 Schneck, 1970, Cerebral neoplasms associated with renal transplantation, Arch Neurol, 23, 226, 10.1001/archneur.1970.00480210036004 Schneck, 1971, De-novo brain tumours in renal-transplant recipients, Lancet, 1, 983, 10.1016/S0140-6736(71)91384-5 So, 1986, Primary central nervous system lymphoma in acquired immune deficiency syndrome: A clinical and pathological study, Ann Neurol, 20, 566, 10.1002/ana.410200503 Starzl, 1971, Iatrogenic alterations of immunologic surveillance in man and their influence on malignancy, Transplant Rev, 7, 112 Starzl, 1984, Reversibility of lymphomas and lymphoproliferative lesions developing under cyclosporin-steroid therapy, Lancet, 1, 583, 10.1016/S0140-6736(84)90994-2 Strauch, 1974, Oropharyngeal excretion of Epstein-Barr virus by renal transplant recipients and other patients treated with immunosuppressive drugs, Lancet, 1, 234, 10.1016/S0140-6736(74)92546-X Thomas, 1959, Discussion, 529 Weintraub, 1982, Lymphoma in cardiac allotransplant recipients, Transplantation, 33, 347, 10.1097/00007890-198204000-00002 Wiznitzer, 1984, Neurological complications of bone marrow transplantation in childhood, Ann Neurol, 16, 569, 10.1002/ana.410160507 Woodman, 1985, Primary non-Hodgkin’s lymphoma of the brain: A review, Medicine, 64, 425, 10.1097/00005792-198511000-00006